Product information

Product name
Linezolid Accord 2 mg/ml
Pack
10 x 300 ml
Active ingredient
linezolid
CNK Code
3716149
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
165800-03-3
ATC code
J01XX08
Company
Accord Healthcare
Pharmaceutical form
Solution for infusion
Ex-factory price
€286.08
Authorisation number
BE522062
GTIN
05055565753835
Delivery mode
M44
Delivery environment
Public
CTI Extended
522062-01

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Active ingredient not available) and no stock is available from wholesalers. Switching to an alternative is necessary.

Assessment no alternative
No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Active ingredient not available

Alternative available

Composition

3 ingredients

Ingredients
Substance Type Strength CAS
Substance
Linezolid
Type
Active ingredient
Strength
600 mg
CAS
165800-03-3
Substance
Glucosemonohydraat
Type
Excipient
Strength
15.07 g
CAS
Substance
Natriumhydroxide
Type
Excipient
Strength
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
469 days
Number of status changes
2
Active supply problems
0
Last change
25/11/2025